 CAMBRIDGE, Mass., Jan. 19, 2021 GLOBE NEWSWIRE -- Mersana Therapeutics, Inc. Nasdaq: MRSN, a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates ADCs targeting cancers in areas of high unmet medical need, today announced that Carla Poulson has joined the company as Chief Human Resources Officer. 